J.-A. Seah, “Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process”, CUAJ, vol. 7, no. 9-10, pp. 312–8, Oct. 2013.